| abstract |
Provided herein is a method for treating a human subject afflicted with ALS by administering to the subject a therapeutically effective amount of pridopidine or pharmaceutically acceptable salt thereof in combination with sodium phenylbutyrate (PB), tauroursodeoxy cholic acid, combination of sodium phenylbutyrate (PB )/tauroursodeoxy cholic acid (i.e. AMX0035), Zilucoplan, Verdiperstat, CNM-Au8 nanocrystalline gold, SLS-005 (trehalose), IC14 or combination thereof as combination or add-on therapy. |